Grifols is a Spanish multinational pharmaceutical and chemical company. Principally a producer of blood plasma-based products.
Grifols is dedicated to hemotherapy, or the treatment of medical conditions using blood or blood components. Grifols’ hemotherapy products are made from human plasma, the liquid portion of human blood that contains essential proteins required for normal physical and neurologic function.
Grifols extracts the proteins from human plasma and uses them to produce therapeutic medicines for the treatment of rare, chronic and life-threatening conditions.
Grifols is the major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products.
For more information: